Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management
Tivya Kulasegaran, Niara Oliveira
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 7, pp. 914-931
Open Access | Times Cited: 11

Showing 11 citing articles:

DNA Repair Capacity and Clinicopathological Characteristics in Puerto Rican Hispanic/Latino Patients with Metastatic Castration-Resistant Prostate Cancer
Jaime Matta, Carmen Ortíz, Jarline Encarnación-Medina, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 279-279
Open Access
Advances in Illuminating Prostate Cancer with Emerging Phototherapies
AminuM Usman
annals of urologic oncology (2025)
Open Access
miRNA Signatures as Predictors of Therapy Response in Castration-Resistant Prostate Cancer: Insights from Clinical Liquid Biopsies and 3D Culture Models
Jonathan Puente-Rivera, Stephanie I. Núñez-Olvera, Verónica Fernández-Sánchez, et al.
Genes (2025) Vol. 16, Iss. 2, pp. 180-180
Open Access
The efficacy and safety of 225Ac-PSMA-617 in metastatic castration-resistant prostate cancer
Jiao Ma, Liang Yu, Jiangchu Yangqing, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Assessment of the therapeutic efficacy of [177Lu]Lu-PSMA-X compared to taxane chemotherapy in taxane-chemo-naïve patients with metastatic castration-resistant prostate cancer: A systematic review and meta-analysis
Ludmila Santiago Almeida, Irene García Megías, Elba Etchebehere, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Closed Access | Times Cited: 2
Periprostatic adipose tissue inhibits tumor progression by secreting apoptotic factors: A natural barrier induced by the immune response during the early stages of prostate cancer
I‐Hung Shao, Tzu-Hsuan Chang, Ying‐Hsu Chang, et al.
Oncology Letters (2024) Vol. 28, Iss. 4
Open Access | Times Cited: 1
Leveraging PARP-1/2 to Target Distant Metastasis
Mallory I. Frederick, Djihane Abdesselam, Anna Clouvel, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9032-9032
Open Access | Times Cited: 1
Efficacy and safety of combination AKT and Androgen Receptor Signalling Inhibition in Metastatic Castration-Resistant Prostate Cancer: systematic review and meta-analysis.
Tulika Ashok Kumar Nahar, Maria Anna Bantounou, Isabella Savin, et al.
Clinical Genitourinary Cancer (2024) Vol. 22, Iss. 6, pp. 102244-102244
Open Access
Transmembrane prostatic acid phosphatase: a therapeutic target in advanced prostate cancer
Alexander Kirschenbaum, Pamela Cheung, Vinodh Rajagopalan, et al.
American Journal of Clinical and Experimental Urology (2024) Vol. 12, Iss. 5, pp. 255-265
Closed Access
Assessment of Patient and Clinician Perspectives on Clinically Meaningful Extension of Progression-free Survival in Prostate Cancer
Ek Leone Oh, Wade Huish, Sara El-Gamil, et al.
European Urology Open Science (2024) Vol. 70, pp. 175-182
Closed Access
Acetyltransferase NAT10 promotes an immunosuppressive microenvironment by modulating CD8+ T cell activity in prostate cancer
Liu Ji, Zhuoran Gu, Libin Zou, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access
Page 1

Scroll to top